Efficacy of telcagepant in subgroups: pooled analysis of data from phase 3 studies

被引:0
|
作者
Ho, T. W. [1 ]
Connor, K. M. [1 ]
Ho, A. P. [1 ]
Kost, J. T. [1 ]
Fan, X. [1 ]
Dodick, D. W. [2 ]
Silberstein, S. D. [3 ]
Lines, C. R. [1 ]
Assaid, C. [1 ]
机构
[1] Merck & Co Inc, N Wales, PA USA
[2] Mayo Clin, Phoenix, AZ USA
[3] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
来源
JOURNAL OF HEADACHE AND PAIN | 2010年 / 11卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
200
引用
收藏
页码:S40 / S41
页数:2
相关论文
共 50 条
  • [41] POOLED EFFICACY AND SAFETY FROM PHASE 3 PLACEBO-CONTROLLED STUDIES OF TANEZUMAB IN PATIENTS WITH OSTEOARTHRITIS
    Tive, L.
    Radin, D.
    Bello, A.
    Brown, M.
    West, C.
    Verburg, K.
    OSTEOARTHRITIS AND CARTILAGE, 2015, 23 : A355 - A355
  • [42] Effect of fezolinetant on moderate-to-severe vasomotor symptoms in subgroups based on hormone therapy history: pooled data from two randomized phase 3 studies
    Santoro, Nanette
    Neal-Perry, Genevieve
    Stute, Petra
    Blogg, Martin
    Mancuso, Shayna
    Morga, Antonia
    Ottery, Faith D.
    Siddiqui, Emad
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1259 - 1259
  • [43] EFFICACY AND SAFETY OF SARILUMAB IN SUBGROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS FROM 2 PHASE-3 STUDIES
    Genovese, M. C.
    Fleischmann, R.
    Mangan, E. K.
    Iglesias-Rodriguez, M.
    Huizinga, T. W. J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S68 - S69
  • [44] Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies
    Panaccione, Remo
    Lofberg, Robert
    Rutgeerts, Paul
    Sandborn, WilliamJ
    Schreiber, Stefan
    Berg, Sofie
    Maa, Jen-Fue
    Petersson, Joel
    Robinson, AnneM
    Colombel, Jean-Frederic
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (06): : 725 - 734
  • [45] EFFICACY OF KARXT ON NEGATIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA: AN ANALYSIS OF POOLED DATA FROM 3 TRIALS
    Vuocolo, Scott
    Horan, William P.
    Claxton, Amy
    Targum, Steven D.
    Kaul, Inder
    Sawchak, Sharon
    Miller, Andrew C.
    Paul, Steven M.
    Brannan, Stephen K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : 358 - 359
  • [47] Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies
    Deodhar, Atul A.
    Miceli-Richard, Corine
    Baraliakos, Xenofon
    Marzo-Ortega, Helena
    Gladman, Dafna D.
    Blanco, Ricardo
    Das Gupta, Ayan
    Martin, Ruvie
    Safi, Jorge
    Porter, Brian
    Shete, Abhijit
    Rosenbaum, James T.
    ACR OPEN RHEUMATOLOGY, 2020, 2 (05) : 294 - 299
  • [48] Efficacy and safety outcomes with odevixibat treatment: Pooled data from the phase 3 ASSERT and ASSERT-EXT studies in patients with Alagille syndrome
    Ovchinsky, Nadia
    Aumar, Madeleine
    Baker, Alastair
    Baumann, Ulrich
    Bufler, Philip
    Cananzi, Mara
    Durmaz, Ozlem
    Fischer, Ryan
    Indolfi, Giuseppe
    Karnsakul, Wikrom
    Lacaille, Florence
    Lee, Way Seah
    Maggiore, Giuseppe
    Rosenthal, Philip
    Ruiz, Mathias
    Sokal, Etienne
    Sturm, Ekkehard
    van der Woerd, Wendy L.
    Verkade, Henkjan J.
    Wehrman, Andrew
    Clemson, Christine
    Yu, Qifeng
    Ni, Quanhong
    Ruvido, Jessica
    Manganaro, Susan
    Mattsson, Jan
    Czubkowski, Piotr
    JOURNAL OF HEPATOLOGY, 2023, 78 : S965 - S966
  • [49] COMPARISON OF TOFACITINIB EFFICACY IN PATIENTS WITH MODERATE VS SEVERE RHEUMATOID ARTHRITIS: POOLED ANALYSIS OF PHASE 3 STUDIES
    Schwartzman, S.
    Sunkureddi, P.
    Takiya, L.
    Snyder, M.
    Fan, H.
    Lukic, T.
    Roberts, J.
    Rigby, W. F. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1202 - 1203
  • [50] Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials
    Shapiro, Michael D.
    Taub, Pam R.
    Louie, Michael J.
    Lei, Lei
    Ballantyne, Christie M.
    ATHEROSCLEROSIS, 2023, 378